- Home
- EL vs ONC Comparison
EL vs ONC Comparison
Compare EL & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EL
- ONC
- Stock Information
- Founded
- EL 1946
- ONC 2010
- Country
- EL United States
- ONC Switzerland
- Employees
- EL N/A
- ONC N/A
- Industry
- EL Package Goods/Cosmetics
- ONC Biotechnology: Pharmaceutical Preparations
- Sector
- EL Consumer Discretionary
- ONC Health Care
- Exchange
- EL Nasdaq
- ONC Nasdaq
- Market Cap
- EL 31.2B
- ONC 37.3B
- IPO Year
- EL 1995
- ONC N/A
- Fundamental
- Price
- EL $95.81
- ONC $330.18
- Analyst Decision
- EL Buy
- ONC Strong Buy
- Analyst Count
- EL 20
- ONC 10
- Target Price
- EL $88.20
- ONC $344.70
- AVG Volume (30 Days)
- EL 2.9M
- ONC 230.5K
- Earning Date
- EL 10-30-2025
- ONC 11-11-2025
- Dividend Yield
- EL 1.51%
- ONC N/A
- EPS Growth
- EL N/A
- ONC N/A
- EPS
- EL N/A
- ONC N/A
- Revenue
- EL $14,326,000,000.00
- ONC $4,562,002,000.00
- Revenue This Year
- EL $6.11
- ONC $881.07
- Revenue Next Year
- EL $4.22
- ONC N/A
- P/E Ratio
- EL N/A
- ONC N/A
- Revenue Growth
- EL N/A
- ONC 47.33
- 52 Week Low
- EL $48.37
- ONC $170.99
- 52 Week High
- EL $97.44
- ONC $355.30
- Technical
- Relative Strength Index (RSI)
- EL 66.22
- ONC 51.32
- Support Level
- EL $87.23
- ONC $334.53
- Resistance Level
- EL $89.90
- ONC $353.00
- Average True Range (ATR)
- EL 2.56
- ONC 6.85
- MACD
- EL 1.06
- ONC -0.67
- Stochastic Oscillator
- EL 100.00
- ONC 33.60
About EL Estee Lauder Companies Inc. (The)
Estée Lauder is a leader in the global prestige beauty market, participating across skin care (49% of fiscal 2025 sales), makeup (29%), fragrance (17%), and hair care and others (5%), with top-selling brands such as Estée Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 31% of revenue from the Americas, 37% from Europe, the Middle East and Africa (including travel retail), and 32% from Asia-Pacific. Estée Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.
About ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.